Abbott Laboratories - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Abbott Laboratories - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary
Marketlines Abbott Laboratories Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Abbott Laboratories since January2007.
Synopsis
Marketlines Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights
This report includes Abbott Laboratoriess contact information and business Summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Abbott Laboratories. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope
- Provides intelligence on Abbott Laboratoriess M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Abbott Laboratories and its subsidiaries since 2007.
- Information about key financial and legal advisors for Abbott Laboratoriess financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Abbott Laboratoriess growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors business structure and growth strategies.
Summary
Marketlines Abbott Laboratories Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Abbott Laboratories since January2007.
Synopsis
Marketlines Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights
This report includes Abbott Laboratoriess contact information and business Summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Abbott Laboratories. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope
- Provides intelligence on Abbott Laboratoriess M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Abbott Laboratories and its subsidiaries since 2007.
- Information about key financial and legal advisors for Abbott Laboratoriess financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Abbott Laboratoriess growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors business structure and growth strategies.
TABLE OF CONTENTS
COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
--Mergers and Acquisitions - Overview
--Mergers and Acquisitions - Deal reports
--Corporate Venturing - Deal reports
PARTNERSHIP
--Partnership - Overview
--Partnership - Deal reports
--Capital Raising - Deal reports
DIVESTMENTS
--Divestments - Overview
--Divestments - Deal reports
APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center
List Of Tables
--Abbott Laboratories activity by deal type - volume (2013 -YTD2017)
--Abbott Laboratories M&A average deal size - value ($m) (2013 -YTD2017)
--Abbott Laboratories legal advisor ranking by value ($m)
--Abbott Laboratories financial advisor ranking by value ($m)
--Top Deals(2013 -YTD2017)
--Abbott Laboratories targets and partners (2013 -YTD2017)
--Abbott Laboratories M&A volume and value trend (2013-YTD2017)
--Abbott Laboratories M&A activity by geography (2013-YTD2017)
--Abbott Laboratories partnership volume and value trend (2013-YTD2017)
--Abbott Laboratories partnership trend by key deal type (2013-YTD2017)
--Abbott Laboratories divestments volume and value trend (2013-YTD2017)
--Abbott Laboratories divestments activity by geography (2013-YTD2017)
List Of Figures
--Abbott Laboratories activity by deal type - volume (2013-YTD2017)
--Abbott Laboratories M&A average deal size - value ($m)
--Abbott Laboratories M&A volume and value trend (2013-YTD2017)
--Abbott Laboratories M&A activity by geography (2013-YTD2017)
--Abbott Laboratories partnership volume and value trend (2013-YTD2017)
--Abbott Laboratories partnership trend by key deal type (2013-YTD2017)
--Abbott Laboratories divestments volume and value trend (2013-YTD2017)
--Abbott Laboratories divestments by geography (2013-YTD2017)
RELATED REPORTS
Musculoskeletal Disorders Drugs Global Market Forecast To 2022 Including: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others - Musculoskeletal Disorders Drugs Covering: F. Hoffmann-La Roche Ltd, GlaxosmithKline Plc, Pfizer Inc, Abbott Laboratories Inc, Daiichi Sankyo Company
The musculoskeletal disorders drugs market consists of sales of musculoskeletal disorders drugs and related services by entities (organizations, sole traders and partnerships) that produce musculoskeletal disorders drugs to treat musculoskeletal
View ReportAntiglaucoma Drugs Global Market Report 2020 Including: 1) By Product Type: Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others 2) By Disease Condition Type: Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma 3) By Type: Hospital Prescription drugs, Over-the counter drugs Covering: Aerie Pharmaceuticals, Inc., ALLERGAN, Novartis AG, Abbott Healthcare, Johnson & Johnson
Antiglaucoma Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market.Reasons
View ReportCOVID-19 Impact on Abbott Laboratories Revenue and Operations (Medical Devices)
COVID-19 Impact on Abbott Laboratories Revenue and Operations (Medical Devices)Abbott is a medical technology company which designs, develops, manufactures and markets a wide range of medical devices, diagnostics, nutritional and
View ReportMedical Devices Global Market Opportunities And Strategies To 2022 Including: By Device Type: In-Vitro Diagnostics, Cardiovascular Devices, Diagnostic Imaging Equipment, Orthopedic Devices, Hospital Supplies, Ophthalmic Devices, Nephrology And Urology Devices, Dental Equipment And Supplies, Wound Care Devices, Diabetes Care Devices, Surgical Equipment, Neurology Devices, Anesthesia And Respiratory Devices, Patient Monitoring Devices, ENT Devices Covering: Medtronic plc, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson And Company, Siemens Healthineers AG
Medical Devices Global Market Opportunities And Strategies To 2022 report provides the strategists, marketers and senior management with the critical information they need to assess the global medical devices market.Reasons
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
